Lineage Switch Subsequently Developed after Isolated Extramedullary Relapse in Children with Acute Myeloid Leukemia / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology
; : 70-74, 2023.
Article
in En
| WPRIM
| ID: wpr-1040602
Responsible library:
WPRO
ABSTRACT
Isolated extramedullary relapse (EMR) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) is relatively rare and the clinical significance is still not well characterized, particularly in children. During or after chemotherapy, an uncommon event termed lineage switch, in which the lineage at onset of leukemia converts to another lineage at a later time, is observed in a subset of leukemia patients, but it is a rare event. We report a 10-year-old boy with isolated mediastinal EMR after allo-HSCT for AML who subsequently experienced BM relapse with the cell lineage switching from AML to T-cell acute lymphoblastic leukemia.
Full text:
1
Index:
WPRIM
Language:
En
Journal:
Clinical Pediatric Hematology-Oncology
Year:
2023
Type:
Article